"Crovalimab could potentially become the first global drug originating from Singapore"

… for patients. These novel antibody technologies enable Chugai … technology. Chugai’s novel proprietary antibody engineering and … in Singapore. Our aim is to combine novel findings … has multiple partnerships within Singapore’s scientific community, including …